Business News

Professional Services News

IntelGenx Receives Health Canada Clearance to Begin Phase 2a Study with Montelukast Versafilm(TM) in Mild to Moderate Alzheimer’s Disease

SAINT-LAURENT, QUEBEC–(Marketwired – Dec. 15, 2017) - IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) (the “Company” or “IntelGenx”) is pleased to announce that [...]

Three Key Ways ICH E6 (R2) Impacts Study Oversight, New Webinar Hosted by Xtalks

TORONTO, ON–(Marketwired – December 15, 2017) – How can stronger relationships be built between sponsors and CROs? How can the sharing of trial data improve trial outcomes? What [...]

ICC International Cannabis Corporation Changes its Name to ICC Labs Inc. to Reflect Medicinal and Pharmaceutical Opportunity

VANCOUVER, BRITISH COLUMBIA–(Marketwired – Dec. 14, 2017) - ICC Labs Inc. (“ICC Labs” or the “Company“) (TSX VENTURE:ICC), a fully licensed producer and [...]

Maricann Announces Upsize of Previously Announced Private Placement

TORONTO, ONTARIO–(Marketwired – Dec. 14, 2017) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Maricann Group Inc. [...]

Corbus Pharmaceuticals Initiates “RESOLVE-1″ Phase 3 Study in Systemic Sclerosis

NORWOOD, MA–(Marketwired – December 14, 2017) – Systemic sclerosis is a rare, serious chronic autoimmune disease with no approved therapy Affects approximately 90,000 [...]

Effective Implementation of the Revised EMA First-into-Human (FIH) Guidance to Accelerate Your Early Clinical Development, New Webinar Hosted by Xtalks

TORONTO, ON–(Marketwired – December 14, 2017) – In this webinar speakers from Simbec Research will discuss the use of integrated protocols (umbrella protocols) to maximise [...]

Vernalis PLC: AGM Statement

WINNERSH, UNITED KINGDOM–(Marketwired – Dec 14, 2017) – Vernalis PLC (LSE: VER) 14 December 2017 LSE: VER AGM Statement Tuzistra® XR prescriptions continue to grow steadily, [...]

Helix BioPharma Corp. Announces Fiscal First Quarter 2018 Results

RICHMOND HILL, ONTARIO–(Marketwired – Dec. 13, 2017) - Helix BioPharma Corp. (TSX:HBP) (FRANKFURT:HBP), an immuno-oncology company developing drug candidates for the prevention and [...]

Tetra Bio-Pharma Reinforces its Development Program by Signing Research & Development Agreement with Constance Therapeutics and Receiving Financial Support from NSERC

OTTAWA, ONTARIO–(Marketwired – Dec. 13, 2017) - Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in [...]

VistaGen Announces Closing of $15,000,000 Underwritten Offering of Common Stock and Warrants to Purchase Common Stock

SOUTH SAN FRANCISCO, CA–(Marketwired – December 13, 2017) – VistaGen Therapeutics, Inc. (NASDAQ: VTGN) (“VistaGen” or the “Company”), a clinical-stage [...]

page  1  of  39